Eriko Watanabe
R&D Management Headquarters, Kaisei Machi
Kanagawa, Japan
Kanagawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Discovery of a new pyrimidine synthesis inhibitor eradicating glioblastoma-initiating cells.
Journal: Neuro-oncology
Published: September 10, 2019
Optical correlation-based cross-domain image retrieval system.
Journal: Optics letters
Published: September 29, 2017
JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression.
Journal: International journal of oncology
Published: September 01, 2013
High-precision microscopic phase imaging without phase unwrapping for cancer cell identification.
Journal: Optics letters
Published: April 19, 2013
Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.
Journal: Stem cell research
Published: March 11, 2013
Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.
Journal: Stem cell research
Published: January 07, 2013
Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK.
Journal: Stem cells translational medicine
Published: December 01, 2012
Targeting JNK for therapeutic depletion of stem-like glioblastoma cells.
Journal: Scientific reports
Published: April 19, 2012
MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis.
Journal: Stem cells (Dayton, Ohio)
Published: September 30, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026